Innate lymphoid cells type 3 in cancer

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Cancer involves complex interactions between tumor cells and host immune cells.
• Innate lymphoid cells (ILCs) are emerging as key players in the tumor microenvironment.
• ILC3s exhibit controversial roles in cancer immunity, with potential roles in both anti-tumor responses and tumor promotion.

Purpose of the Study:

• To review current research on the involvement of ILC3s in cancer development.
• To highlight the dual role of ILC3s in tumor immunity.
• To emphasize the context-dependent functions of ILC3s in various organs.

Main Methods:

• Literature review of recent studies on ILC3s and cancer.
• Analysis of ILC3 involvement in carcinogenesis.
• Examination of ILC3 activity in different tissue microenvironments.

Main Results:

• ILC3s can enhance anti-tumor immunity by facilitating immune cell infiltration.
• IL-23-stimulated ILC3s may paradoxically promote tumor growth.
• The function of ILC3s in cancer is highly dependent on the specific tissue microenvironment and ILC3 subtype.

Conclusions:

• ILC3s have a complex and context-dependent role in cancer immunity.
• Understanding the specific functions of ILC3s in different cancers is crucial for developing effective immunotherapies.
• Further research is needed to elucidate the precise mechanisms underlying ILC3 involvement in carcinogenesis across various organs.